Glenmark Pharma

Glenmark Pharma pushes first generic product in Europe with asthma drug in Denmark

Glenmark said it has already received National Marketing Authorizations for the product in Sweden, Finland, Norway and Iceland.

Dr Reddy's Lab, Sun Pharma, Glenmark among 18 under US lens on price fixing complaint

In July 2014, the state of Connecticut started a probe -- later joined by other states -- into suspicious price increase of certain generics by up to 1,000 percent or more

Glenmark Pharma gets USFDA approval to manufacture generic version of hypertension drug Bystolic

According to IMS Health sales data for the 12 months to March 2017, the Bystolic tablets achieved annual sales of approximately $1 billion

Glenmark, Particle Sciences enter deal to develop generic cancer drug

As per the terms of the agreement, Glenmark has obtained global exclusive marketing and distribution rights of the product upon commercialisation

Glenmark Pharma to raise over Rs 1,300 cr via bonds issuance to repay debt

These bonds are planned to be listed on the Singapore Stock Exchange

Glenmark receives USFDA approval for anti-fungal ointment

According to IMS Health sales data for the 12 months to April 2016, Glenmark said Nystatin and triamcinolone acetonide ointment achieved annual sales of around $37.5 million

Glenmark's US arm receives US FDA approval for contraceptive tablets

Glenmark gets tentative USFDA approval for Lacosamide tablets

Lacosamide Tablets is generic version of Vimpat Tablets of UCB Inc

Glenmark Pharma on roll, hits new 52-week high on spate of recent approvals

In addition to today's gains, the stock has rallied 15 percent so far in last six trading sessions

10 things you need to know before the opening bell

Wall Street retreated on Wednesday, the second day of a partial U.S. government shutdown, as political wrangling in Washington raised investor concerns that the stoppage could be prolonged.